Disruption Clifford E Carnicom Apr 23 2024 A measure of success has been achieved at disrupting the early stage growth of the Cross Domain Bacteria (CDB, nomenclature, 2014), a genetically engineered, xenobiotic, synthetic biology life form under study by Carnicom Institute(CI). The harm from this biology upon humans (and upon life in general) has ample discussion within the CI site and will not be repeated here. The expected relationships of this synthetic biology, with an origin of d...| carnicominstitute.org
Pandora’s Polymer : Synthetic Blood and the Cross Domain Bacteria (CDB)| Carnicom Institute
Blood, Covid & Cross Domain Bacteria (CDB) : Emerging Relationships| Carnicom Institute
In this series of articles, we describe our analysis of multiple blood clots received and our preliminary results.| anamihalceamdphd.substack.com